Income Statement Corpay, Inc.

Equities

CPAY

US2199481068

Business Support Services

Market Closed - Nyse Other stock markets 21:00:02 20/01/2026 GMT			5-day change	1st Jan Change
305.25 ^USD	-4.81%		-7.80%	+1.44%

01-13	Corpay Pick of the Week at Smart Insider Following Non-Executive Steven Stull Stock Purchase	MT
01-12	Oppenheimer Adjusts Corpay Price Target to $369 From $380, Maintains Outperform Rating	MT

6e60980c19d78cc089.ER8F5zb7S0RBbXLt68JxFvE81YS_hWesMm6EKDwywzY.KG5_g3LWMiZ4CDaXmp0bYcJYrOLb1SHdWQjiEUx_gGUiVV-pBL1yBTlYAQ

Published financial data: CORPAY, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	2.39B	2.83B	3.43B	3.76B	3.97B
Total Revenues	2.39B	2.83B	3.43B	3.76B	3.97B
Cost of Goods Sold, Total	506M	560M	765M	820M	869M
Gross Profit	1.88B	2.27B	2.66B	2.94B	3.11B
Selling General & Admin Expenses, Total	567M	748M	893M	944M	998M
Depreciation & Amortization - (IS)	255M	284M	322M	337M	351M
Other Operating Expenses	-2.28M	-984K	282K	753K	789K
Other Operating Expenses, Total	820M	1.03B	1.22B	1.28B	1.35B
Operating Income	1.06B	1.24B	1.45B	1.66B	1.76B
Interest Expense, Total	-130M	-114M	-165M	-349M	-383M
Interest And Investment Income	30.01M	9K	-	116K	-
Net Interest Expenses	-99.8M	-114M	-165M	-348M	-383M
Income (Loss) On Equity Invest.	-	-	-	-	-
Currency Exchange Gains (Loss)	2.9M	-3.7M	-1.7M	-4.8M	-9.2M
Other Non Operating Income (Expenses)	155K	-158K	-1.3M	7.71M	-4.52M
EBT, Excl. Unusual Items	966M	1.13B	1.28B	1.31B	1.36B
Impairment of Goodwill	-	-	-	-	-90M
Gain (Loss) On Sale Of Investments	-	-	-1.38M	-	-239K
Gain (Loss) On Sale Of Assets	-	-	-	13.71M	121M
Asset Writedown	-294K	-200K	-	-	-
Other Unusual Items	-83.06M	-16.19M	-1.93M	-	-5.04M
EBT, Incl. Unusual Items	883M	1.11B	1.28B	1.33B	1.39B
Income Tax Expense	178M	269M	321M	343M	381M
Earnings From Continuing Operations	704M	839M	954M	982M	1B
Net Income to Company	704M	839M	954M	982M	1B
Minority Interest	-	-	-	-	14K
Net Income - (IS)	704M	839M	954M	982M	1B
Net Income to Common Incl Extra Items	704M	839M	954M	982M	1B
Net Income to Common Excl. Extra Items	704M	839M	954M	982M	1B
Per Share Items
Net EPS - Basic	8.38	10.23	12.62	13.42	14.27
Basic EPS - Continuing Operations	8.38	10.23	12.62	13.42	14.27
Basic Weighted Average Shares Outstanding	84M	82.06M	75.6M	73.16M	70.33M
Net EPS - Diluted	8.12	9.99	12.42	13.2	13.97
Diluted EPS - Continuing Operations	8.12	9.99	12.42	13.2	13.97
Diluted Weighted Average Shares Outstanding	86.72M	84.06M	76.86M	74.39M	71.85M
Normalized Basic EPS	7.19	8.57	10.57	11.2	12.08
Normalized Diluted EPS	6.96	8.37	10.4	11.02	11.82
American Depositary Receipts Ratio (ADR)	0.25	0.25	0.25	0.25	0.25
Supplemental Items
EBITDA	1.27B	1.48B	1.71B	1.99B	2.11B
EBITA	1.25B	1.45B	1.67B	1.88B	1.99B
EBIT	1.06B	1.24B	1.45B	1.66B	1.76B
EBITDAR	1.29B	1.5B	1.73B	-	2.13B
Effective Tax Rate - (Ratio)	20.2	24.29	25.19	25.9	27.53
Current Domestic Taxes	90.72M	151M	201M	181M	177M
Current Foreign Taxes	71.92M	108M	153M	209M	270M
Total Current Taxes	163M	258M	355M	390M	446M
Deferred Domestic Taxes	-4.18M	-16.7M	-42.68M	-54.76M	-81.27M
Deferred Foreign Taxes	19.85M	27.73M	9.5M	8.09M	16.55M
Total Deferred Taxes	15.67M	11.02M	-33.17M	-46.68M	-64.72M
Normalized Net Income	604M	703M	799M	820M	849M
Supplemental Operating Expense Items
Advertising Expense	28.5M	54.8M	65.5M	64.6M	75M
Selling and Marketing Expenses	193M	262M	309M	340M	381M
General and Administrative Expenses	375M	486M	584M	603M	617M
Research And Development Expense From Footnotes	40.2M	46.7M	59.1M	-	-
Net Rental Expense, Total	20.7M	22.6M	24.1M	-	26.9M
Imputed Operating Lease Interest Expense	4.43M	3.88M	4.79M	-	11M
Imputed Operating Lease Depreciation	16.27M	18.72M	19.31M	-	15.9M
Stock-Based Comp., G&A Exp. (Total)	43.38M	80.07M	121M	116M	117M
Stock-Based Comp., Other (Total)	-	-	-	-	-
Total Stock-Based Compensation	43.38M	80.07M	121M	116M	117M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	935M	1.52B	1.44B	1.39B	1.55B
Trading Asset Securities, Total	-	-	-	23.5M	32.3M
Total Cash And Short Term Investments	935M	1.52B	1.44B	1.41B	1.59B
Accounts Receivable, Total	2.07B	2.91B	3.35B	3.47B	3.41B
Total Receivables	2.07B	2.91B	3.35B	3.47B	3.41B
Prepaid Expenses	259M	216M	243M	177M	124M
Deferred Tax Assets Current	-	-	-	-	-
Restricted Cash	542M	731M	854M	1.75B	2.9B
Other Current Assets, Total	154M	110M	222M	273M	650M
Total Current Assets	3.96B	5.49B	6.11B	7.08B	8.68B
Gross Property Plant And Equipment	545M	650M	670M	945M	1.03B
Accumulated Depreciation	-266M	-329M	-281M	-515M	-576M
Net Property Plant And Equipment	279M	321M	389M	430M	456M
Long-term Investments	7.48M	52.02M	74.28M	69.52M	70.09M
Goodwill	4.72B	5.08B	5.2B	5.64B	5.98B
Other Intangibles, Total	2.12B	2.34B	2.13B	2.09B	2.41B
Deferred Charges Long-Term	43.6M	44.7M	50.7M	50.6M	48M
Other Long-Term Assets, Total	72.81M	84.46M	136M	112M	312M
Total Assets	11.19B	13.4B	14.09B	15.48B	17.96B
Liabilities
Accounts Payable, Total	1.05B	1.41B	1.57B	1.62B	1.57B
Accrued Expenses, Total	204M	275M	257M	247M	316M
Short-term Borrowings	1.04B	1.34B	1.29B	2B	2.58B
Current Portion of Long-Term Debt	211M	198M	1.03B	142M	189M
Current Portion of Leases	17M	20.3M	22.66M	23.48M	24.34M
Current Income Taxes Payable	78.77M	93.63M	94.56M	109M	129M
Other Current Liabilities	1.36B	1.95B	1.79B	2.68B	3.89B
Total Current Liabilities	3.97B	5.29B	6.04B	6.83B	8.71B
Long-Term Debt	3.17B	4.47B	4.72B	4.65B	5.24B
Long-Term Leases	75.4M	79.9M	86.67M	75.8M	64.72M
Unearned Revenue Non Current	-	30.4M	-	-	-
Deferred Tax Liability Non Current	498M	566M	527M	470M	439M
Other Non Current Liabilities	132M	104M	167M	170M	362M
Total Liabilities	7.84B	10.54B	11.55B	12.19B	14.81B
Common Stock, Total	126K	127K	128K	129K	131K
Additional Paid In Capital	2.75B	2.88B	3.05B	3.27B	3.81B
Retained Earnings	5.42B	6.26B	7.21B	8.19B	9.2B
Treasury Stock	-3.45B	-4.8B	-6.21B	-6.89B	-8.17B
Comprehensive Income and Other	-1.36B	-1.46B	-1.51B	-1.29B	-1.71B
Total Common Equity	3.36B	2.87B	2.54B	3.28B	3.12B
Minority Interest	-	-	-	-	23.65M
Total Equity	3.36B	2.87B	2.54B	3.28B	3.15B
Total Liabilities And Equity	11.19B	13.4B	14.09B	15.48B	17.96B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	83.42M	77.89M	73.49M	71.85M	70.25M
ECS Total Common Shares Outstanding	83.67M	78.88M	73.36M	71.72M	70.17M
Book Value / Share	40.1	36.34	34.65	45.77	44.5
Tangible Book Value	-3.48B	-4.55B	-4.79B	-4.45B	-5.27B
Tangible Book Value Per Share	-41.59	-57.65	-65.31	-62.03	-75.14
Total Debt	4.51B	6.11B	7.15B	6.89B	8.1B
Net Debt	3.58B	4.59B	5.71B	5.48B	6.51B
Debt Equivalent Oper. Leases	166M	181M	193M	-	215M
Minority Interest, Total (Incl. Fin. Div)	-	-	-	-	23.65M
Equity Method Investments, Total	-	-	-	-	-
Account Code - Inventory Valuation	3	3	-	-	3
Buildings, Total	30.47M	33.52M	36.1M	41.51M	40.24M
Machinery, Total	438M	532M	539M	817M	914M
Full Time Employees	8.4K	9.7K	9.9K	10.5K	11.2K
Accumulated Allowance for Doubtful Accounts (Supple)	86.89M	98.72M	150M	180M	134M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	704M	839M	954M	982M	1B
Depreciation & Amortization - CF	24.98M	28.87M	32.91M	110M	120M
Amortization of Goodwill and Intangible Assets - (CF)	184M	206M	227M	227M	231M
Depreciation & Amortization, Total	209M	234M	260M	337M	351M
Amortization of Deferred Charges, Total - (CF)	46.69M	53.53M	66.85M	7.25M	7.99M
(Gain) Loss From Sale Of Asset	-	-	-	-13.71M	-121M
(Gain) Loss on Sale of Investments - (CF)	-30.01M	-9K	1.38M	-	-
Asset Writedown & Restructuring Costs	-	-	-	-	90M
(Income) Loss On Equity Investments - (CF)	-	-	-	-	-
Stock-Based Compensation (CF)	43.38M	80.07M	121M	116M	117M
Provision and Write-off of Bad Debts	159M	37.92M	131M	125M	103M
Other Operating Activities, Total	-11.68M	29.56M	-27.89M	-46.04M	-58.48M
Change In Accounts Receivable	264M	-731M	-599M	-210M	-177M
Change In Accounts Payable	89.98M	430M	-83.95M	714M	663M
Change in Other Net Operating Assets	-1.86M	223M	-69.87M	90.19M	-38.44M
Cash from Operations	1.47B	1.2B	755M	2.1B	1.94B
Capital Expenditure	-78.42M	-112M	-151M	-154M	-175M
Sale of Property, Plant, and Equipment	-	-	-	-	-
Cash Acquisitions	-80.79M	-602M	-217M	-428M	-822M
Divestitures	-	-	-	197M	186M
Investment in Marketable and Equity Securities, Total	52.96M	-	-	-	-
Other Investing Activities, Total	-	-2.28M	-	4.4M	4.12M
Cash from Investing	-106M	-716M	-368M	-381M	-807M
Short Term Debt Issued, Total	-	418M	169M	156M	16M
Long-Term Debt Issued, Total	1.24B	3.81B	10.24B	8.73B	10.81B
Total Debt Issued	1.24B	4.23B	10.41B	8.89B	10.83B
Short Term Debt Repaid, Total	-272M	-51.05M	-	-	-141M
Long-Term Debt Repaid, Total	-1.67B	-2.49B	-9.35B	-9.21B	-9.42B
Total Debt Repaid	-1.94B	-2.54B	-9.35B	-9.21B	-9.56B
Issuance of Common Stock	137M	48.78M	49.4M	114M	428M
Repurchase of Common Stock	-850M	-1.36B	-1.41B	-687M	-1.29B
Other Financing Activities, Total	-2.98M	-39.73M	-10.63M	-2.66M	-6.47M
Cash from Financing	-1.42B	344M	-311M	-898M	405M
Foreign Exchange Rate Adjustments	-148M	-50.98M	-36.74M	30.16M	-223M
Net Change in Cash	-199M	774M	38.48M	852M	1.31B
Supplemental Items
Cash Interest Paid	126M	133M	230M	448M	496M
Cash Income Tax Paid (Refund)	165M	230M	358M	408M	374M
Levered Free Cash Flow	1.13B	1.05B	373M	1.07B	988M
Unlevered Free Cash Flow	1.2B	1.11B	468M	1.28B	1.22B
Change In Net Working Capital	-323M	-86.16M	725M	57.84M	170M
Net Debt Issued / Repaid	-701M	1.69B	1.06B	-322M	1.27B

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	5.67	6.32	6.58	7	6.56
Return on Total Capital	7.92	9.24	9.69	10.43	10.25
Return On Equity %	19.93	26.98	35.29	33.72	31.23
Return on Common Equity	19.93	26.98	35.29	33.72	31.34
Margin Analysis
Gross Profit Margin %	78.81	80.24	77.69	78.18	78.13
SG&A Margin	23.75	26.39	26.06	25.11	25.1
EBITDA Margin %	53.24	52.13	49.8	53.05	53.01
EBITA Margin %	52.19	51.11	48.84	50.12	49.98
EBIT Margin %	44.48	43.86	42.21	44.09	44.18
Income From Continuing Operations Margin %	29.48	29.62	27.85	26.13	25.25
Net Income Margin %	29.48	29.62	27.85	26.13	25.25
Net Avail. For Common Margin %	29.48	29.62	27.85	26.13	25.25
Normalized Net Income Margin	25.27	24.82	23.32	21.81	21.37
Levered Free Cash Flow Margin	47.16	36.99	10.88	28.37	24.86
Unlevered Free Cash Flow Margin	50.28	39.26	13.66	33.97	30.69
Asset Turnover
Asset Turnover	0.2	0.23	0.25	0.25	0.24
Fixed Assets Turnover	8.48	9.44	9.65	9.18	8.98
Receivables Turnover (Average Receivables)	1.04	1.14	1.09	1.1	1.16
Short Term Liquidity
Current Ratio	1	1.04	1.01	1.04	1
Quick Ratio	0.76	0.84	0.79	0.72	0.57
Operating Cash Flow to Current Liabilities	0.37	0.23	0.12	0.31	0.22
Days Sales Outstanding (Average Receivables)	352.9	320.6	333.52	331.24	316.87
Average Days Payable Outstanding	832.79	802.23	710.06	710.93	672.85
Long Term Solvency
Total Debt/Equity	134.5	213.1	281.18	209.99	257.48
Total Debt / Total Capital	57.36	68.06	73.77	67.74	72.03
LT Debt/Equity	96.59	158.63	189.24	144.04	168.53
Long-Term Debt / Total Capital	41.19	50.66	49.65	46.47	47.14
Total Liabilities / Total Assets	70.03	78.62	81.96	78.79	82.48
EBIT / Interest Expense	8.19	10.93	8.79	4.75	4.58
EBITDA / Interest Expense	9.96	13.19	10.51	5.79	5.57
(EBITDA - Capex) / Interest Expense	9.35	12.21	9.59	5.35	5.11
Total Debt / EBITDA	3.49	4.07	4.13	3.42	3.8
Net Debt / EBITDA	2.77	3.06	3.3	2.72	3.05
Total Debt / (EBITDA - Capex)	3.72	4.4	4.52	3.7	4.14
Net Debt / (EBITDA - Capex)	2.95	3.31	3.62	2.94	3.33
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-9.82	18.62	20.94	9.65	5.77
Gross Profit, 1 Yr. Growth %	-11.12	20.79	17.09	10.34	5.71
EBITDA, 1 Yr. Growth %	-13.23	16.14	15.56	12.69	5.75
EBITA, 1 Yr. Growth %	-13.42	16.16	15.59	12.32	5.55
EBIT, 1 Yr. Growth %	-13.84	16.95	16.42	14.53	5.97
Earnings From Cont. Operations, 1 Yr. Growth %	-21.32	19.21	13.68	2.89	2.22
Net Income, 1 Yr. Growth %	-21.32	19.21	13.68	2.89	2.23
Normalized Net Income, 1 Yr. Growth %	-10.82	16.49	13.69	2.53	3.65
Diluted EPS Before Extra, 1 Yr. Growth %	-18.31	23.03	24.32	6.28	5.83
Accounts Receivable, 1 Yr. Growth %	-18.63	40.86	15.13	3.49	-1.59
Net Property, Plant and Equip., 1 Yr. Growth %	-1.7	14.95	21.25	10.54	6.04
Total Assets, 1 Yr. Growth %	-8.6	19.74	5.11	9.84	16.03
Tangible Book Value, 1 Yr. Growth %	0.47	30.7	5.35	-7.15	18.54
Common Equity, 1 Yr. Growth %	-9.6	-14.57	-11.34	29.15	-4.88
Cash From Operations, 1 Yr. Growth %	26.72	-18.71	-36.95	178.37	-7.64
Capital Expenditures, 1 Yr. Growth %	4.33	42.21	35.77	1.58	13.88
Levered Free Cash Flow, 1 Yr. Growth %	58.64	-6.94	-64.42	174.73	-7.18
Unlevered Free Cash Flow, 1 Yr. Growth %	50.38	-7.38	-57.92	164.21	-4.36
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-0.92	3.43	19.78	15.15	7.69
Gross Profit, 2 Yr. CAGR %	-1.64	3.61	18.92	13.66	8
EBITDA, 2 Yr. CAGR %	-2.74	0.39	15.86	14.27	9.23
EBITA, 2 Yr. CAGR %	-2.65	0.28	15.88	13.93	8.94
EBIT, 2 Yr. CAGR %	-1.69	0.39	16.69	15.47	10.17
Earnings From Cont. Operations, 2 Yr. CAGR %	-6.84	-3.15	16.41	8.15	2.56
Net Income, 2 Yr. CAGR %	-6.84	-3.15	16.41	8.15	2.56
Normalized Net Income, 2 Yr. CAGR %	0.29	1.93	14.67	7.96	3.08
Diluted EPS Before Extra, 2 Yr. CAGR %	-4	0.25	23.68	14.95	6.06
Accounts Receivable, 2 Yr. CAGR %	-5.45	7.06	27.35	9.15	0.92
Net Property, Plant and Equip., 2 Yr. CAGR %	22.48	6.3	18.06	15.69	8.27
Total Assets, 2 Yr. CAGR %	-0.04	4.61	12.19	7.45	12.89
Tangible Book Value, 2 Yr. CAGR %	-1.82	14.59	17.34	-1.1	4.91
Common Equity, 2 Yr. CAGR %	0.23	-12.12	-12.97	7.01	10.84
Cash From Operations, 2 Yr. CAGR %	27.67	1.49	-28.41	32.49	60.34
Capital Expenditures, 2 Yr. CAGR %	-1.84	21.81	38.96	17.44	7.56
Levered Free Cash Flow, 2 Yr. CAGR %	36.96	21.5	-42.46	0.7	60.23
Unlevered Free Cash Flow, 2 Yr. CAGR %	32.73	18.02	-37.57	6.98	59.39
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	2.02	5.21	8.97	16.3	11.94
Gross Profit, 3 Yr. CAGR %	3.32	5.33	7.92	15.99	10.95
EBITDA, 3 Yr. CAGR %	4.32	3.19	5.21	16.17	11.33
EBITA, 3 Yr. CAGR %	4.41	3.25	5.14	14.75	11.04
EBIT, 3 Yr. CAGR %	6.34	4.17	5.46	15.97	12.22
Earnings From Cont. Operations, 3 Yr. CAGR %	-1.65	1.14	2.16	11.72	6.14
Net Income, 3 Yr. CAGR %	-1.65	1.14	2.16	11.72	6.14
Normalized Net Income, 3 Yr. CAGR %	7.61	5.42	5.7	10.47	6.5
Diluted EPS Before Extra, 3 Yr. CAGR %	0.88	4.28	7.71	17.58	11.83
Accounts Receivable, 3 Yr. CAGR %	-2.52	7.99	9.69	18.84	5.45
Net Property, Plant and Equip., 3 Yr. CAGR %	15.76	19.91	11.07	15.44	12.38
Total Assets, 3 Yr. CAGR %	-0.37	6.16	4.78	11.4	10.24
Tangible Book Value, 3 Yr. CAGR %	-2.59	8	11.42	8.53	5.05
Common Equity, 3 Yr. CAGR %	-3	-4.97	-11.86	-0.73	2.89
Cash From Operations, 3 Yr. CAGR %	29.37	9.84	-13.4	12.58	17.47
Capital Expenditures, 3 Yr. CAGR %	3.81	11.07	26.3	25.18	16.24
Levered Free Cash Flow, 3 Yr. CAGR %	16.65	20.4	-19.32	-1.82	-2.04
Unlevered Free Cash Flow, 3 Yr. CAGR %	15.99	17.73	-16.32	2.06	3.02
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	7	9.12	8.78	9.08	8.45
Gross Profit, 5 Yr. CAGR %	8.3	10.64	9.3	8.59	7.95
EBITDA, 5 Yr. CAGR %	8.49	9.59	8.78	8.2	7.53
EBITA, 5 Yr. CAGR %	8.55	9.6	8.85	7.44	6.65
EBIT, 5 Yr. CAGR %	9.74	10.51	10.36	8.55	7.32
Earnings From Cont. Operations, 5 Yr. CAGR %	14.21	13.16	5.21	3.89	2.32
Net Income, 5 Yr. CAGR %	14.21	13.16	5.21	3.89	2.32
Normalized Net Income, 5 Yr. CAGR %	10.22	10.62	10.54	6.43	4.64
Diluted EPS Before Extra, 5 Yr. CAGR %	16.1	16.03	9.44	8.42	7.04
Accounts Receivable, 5 Yr. CAGR %	10.53	10.18	8.48	8.45	6.09
Net Property, Plant and Equip., 5 Yr. CAGR %	28.17	17.64	16.67	18.21	9.91
Total Assets, 5 Yr. CAGR %	7.25	6.85	4.48	6.68	7.95
Tangible Book Value, 5 Yr. CAGR %	3.71	3.85	4.94	4.27	8.77
Common Equity, 5 Yr. CAGR %	3.46	-1.45	-7.12	-0.35	-3.4
Cash From Operations, 5 Yr. CAGR %	14.31	11.07	2.11	18.39	10.8
Capital Expenditures, 5 Yr. CAGR %	13.37	13.58	16.66	13.58	18.44
Levered Free Cash Flow, 5 Yr. CAGR %	10.58	9.39	-12.08	12.16	6.84
Unlevered Free Cash Flow, 5 Yr. CAGR %	10.81	9.5	-9.47	13.37	8.84